These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6606140)

  • 1. Multiple sclerosis after age 50.
    Noseworthy J; Paty D; Wonnacott T; Feasby T; Ebers G
    Neurology; 1983 Dec; 33(12):1537-44. PubMed ID: 6606140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Late onset multiple sclerosis].
    Delalande S; De Seze J; Ferriby D; Stojkovic T; Vermersch P
    Rev Neurol (Paris); 2002 Nov; 158(11):1082-7. PubMed ID: 12451340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis with very late onset.
    Hooge JP; Redekop WK
    Neurology; 1992 Oct; 42(10):1907-10. PubMed ID: 1407571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study.
    Guillemin F; Baumann C; Epstein J; Kerschen P; Garot T; Mathey G; Debouverie M;
    Neuroepidemiology; 2017; 48(3-4):179-187. PubMed ID: 28793296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal evoked potentials and CSF findings in the diagnosis of multiple sclerosis.
    Morocutti C; Pozzessere G; Valle E; Mollica MA; Quadrini R; Sanarelli L; Rizzo PA; Amabile G
    Riv Neurol; 1987; 57(3):175-80. PubMed ID: 3672010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of interleukin 2 in the pathogenesis and clinical course of multiple sclerosis].
    Cendrowski W
    Neurol Neurochir Pol; 1986; 20(2):143-6. PubMed ID: 3534619
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapidly progressive course of very late onset multiple sclerosis presenting with Parkinsonism: case report.
    Schultheiss T; Reichmann H; Ziemssen T
    Mult Scler; 2011 Feb; 17(2):245-9. PubMed ID: 20921234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinico-immunological monitoring of the condition of patients with multiple sclerosis].
    Gusev EI; Demina TL; Boĭko AN; Tatarinova MIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(2):14-8. PubMed ID: 1326164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis with onset after age 60.
    Marra TR
    J Am Geriatr Soc; 1984 Jan; 32(1):16-8. PubMed ID: 6197435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts.
    Kingwell E; Leung AL; Roger E; Duquette P; Rieckmann P; Tremlett H;
    J Neurol Sci; 2010 May; 292(1-2):57-62. PubMed ID: 20202651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical picture of multiple sclerosis with late onset.
    Cazzullo CL; Ghezzi A; Marforio S; Caputo D
    Acta Neurol Scand; 1978 Sep; 58(3):190-6. PubMed ID: 716837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS.
    Hardmeier M; Leocani L; Fuhr P
    Mult Scler; 2017 Sep; 23(10):1309-1319. PubMed ID: 28480798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of CSF guanase activity in multiple sclerosis: a comparative study on various parameters to monitor the disease activity].
    Kaneshige Y; Matsumoto H; Chiba S; Hashimoto S; Noro H
    Rinsho Shinkeigaku; 1989 Jul; 29(7):854-8. PubMed ID: 2805507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late onset multiple sclerosis: clinical pattern of optic nerve involvement.
    Safran AB
    Metab Pediatr Syst Ophthalmol (1985); 1989; 12(1-3):58-60. PubMed ID: 2671592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The diagnostic value of nuclear magnetic resonance tomography, multimodal evoked potentials and cerebrospinal fluid examination in multiple sclerosis].
    Staffen W; Trinka E; Ladurner G
    Nervenarzt; 1993 Apr; 64(4):226-32. PubMed ID: 8506010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late onset multiple sclerosis.
    Arias M; Dapena D; Arias-Rivas S; Costa E; López A; Prieto JM; Corredera E
    Neurologia; 2011 Jun; 26(5):291-6. PubMed ID: 21163234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Visual and somatosensory evoked potentials and immunologic indices in multiple sclerosis].
    Mukhtarova AA; Sokolova LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):193-7. PubMed ID: 6608844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria.
    Beer S; Rösler KM; Hess CW
    J Neurol Neurosurg Psychiatry; 1995 Aug; 59(2):152-9. PubMed ID: 7629529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensory (VEP, BAEP, SEP) and motor-evoked potentials, liquoral and magnetic resonance findings in multiple sclerosis.
    Rossini PM; Zarola F; Floris R; Bernardi G; Perretti A; Pelosi L; Caruso G; Caramia MD
    Eur Neurol; 1989; 29(1):41-7. PubMed ID: 2495966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.